702 related articles for article (PubMed ID: 15735125)
1. Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.
Tekautz TM; Fuller CE; Blaney S; Fouladi M; Broniscer A; Merchant TE; Krasin M; Dalton J; Hale G; Kun LE; Wallace D; Gilbertson RJ; Gajjar A
J Clin Oncol; 2005 Mar; 23(7):1491-9. PubMed ID: 15735125
[TBL] [Abstract][Full Text] [Related]
2. Atypical teratoid/rhabdoid tumors of the central nervous system: management and outcomes.
Chen ML; McComb JG; Krieger MD
Neurosurg Focus; 2005 Jun; 18(6A):E8. PubMed ID: 16048294
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study.
Dufour C; Beaugrand A; Le Deley MC; Bourdeaut F; André N; Leblond P; Bertozzi AI; Frappaz D; Rialland X; Fouyssac F; Edan C; Grill J; Quidot M; Varlet P
Cancer; 2012 Aug; 118(15):3812-21. PubMed ID: 22180295
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system atypical teratoid rhabdoid tumours: the Canadian Paediatric Brain Tumour Consortium experience.
Lafay-Cousin L; Hawkins C; Carret AS; Johnston D; Zelcer S; Wilson B; Jabado N; Scheinemann K; Eisenstat D; Fryer C; Fleming A; Mpofu C; Larouche V; Strother D; Bouffet E; Huang A
Eur J Cancer; 2012 Feb; 48(3):353-9. PubMed ID: 22023887
[TBL] [Abstract][Full Text] [Related]
5. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors.
Gardner SL; Asgharzadeh S; Green A; Horn B; McCowage G; Finlay J
Pediatr Blood Cancer; 2008 Aug; 51(2):235-40. PubMed ID: 18381756
[TBL] [Abstract][Full Text] [Related]
6. Clinical and pathological features of paediatric malignant rhabdoid tumours.
Morgenstern DA; Gibson S; Brown T; Sebire NJ; Anderson J
Pediatr Blood Cancer; 2010 Jan; 54(1):29-34. PubMed ID: 19653294
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry.
Hilden JM; Meerbaum S; Burger P; Finlay J; Janss A; Scheithauer BW; Walter AW; Rorke LB; Biegel JA
J Clin Oncol; 2004 Jul; 22(14):2877-84. PubMed ID: 15254056
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system tumors in patients under three years of age: treatment results of a single institute.
Varan A; Akalan N; Söylemezoğlu F; Zorlu F; Yalçin B; Akyüz C; Kutluk T; Büyükpamukçu M
Pediatr Neurosurg; 2006; 42(2):89-94. PubMed ID: 16465077
[TBL] [Abstract][Full Text] [Related]
9. Childhood atypical teratoid rhabdoid tumor of the central nervous system: a meta-analysis of observational studies.
Athale UH; Duckworth J; Odame I; Barr R
J Pediatr Hematol Oncol; 2009 Sep; 31(9):651-63. PubMed ID: 19707161
[TBL] [Abstract][Full Text] [Related]
10. Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database.
von Hoff K; Hinkes B; Dannenmann-Stern E; von Bueren AO; Warmuth-Metz M; Soerensen N; Emser A; Zwiener I; Schlegel PG; Kuehl J; Frühwald MC; Kortmann RD; Pietsch T; Rutkowski S
Pediatr Blood Cancer; 2011 Dec; 57(6):978-85. PubMed ID: 21796761
[TBL] [Abstract][Full Text] [Related]
11. Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis.
Buscariollo DL; Park HS; Roberts KB; Yu JB
Cancer; 2012 Sep; 118(17):4212-9. PubMed ID: 22213196
[TBL] [Abstract][Full Text] [Related]
12. Central nervous system (CNS) tumors in the first six months of life: the Children's Hospital Los Angeles experience, 1979-2005.
Serowka K; Chiu Y; Gonzalez I; Gilles F; McComb G; Krieger M; Dhall G; Britt B; Ji L; Sposto R; Finlay JL
Pediatr Hematol Oncol; 2010 Mar; 27(2):90-102. PubMed ID: 20201690
[TBL] [Abstract][Full Text] [Related]
13. Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohort.
Benesch M; Nemes K; Neumayer P; Hasselblatt M; Timmermann B; Bison B; Ebetsberger-Dachs G; Bourdeaut F; Dufour C; Biassoni V; Morales La Madrid A; Entz-Werle N; Laithier V; Quehenberger F; Weis S; Sumerauer D; Siebert R; Bens S; Schneppenheim R; Kool M; Modena P; Fouyssac F; C Frühwald M
Pediatr Blood Cancer; 2020 Jan; 67(1):e28022. PubMed ID: 31571386
[TBL] [Abstract][Full Text] [Related]
14. Factors Influencing Survival of Children with Atypical Teratoid/Rhabdoid Tumors: A Single-Institute Experience in a Developing Country.
Rao SJB; Konar SK; Shukla D; Bhat DI; Beniwal M; Rao KVLN; Nandeesh BN; Devi BI
World Neurosurg; 2019 Sep; 129():e264-e272. PubMed ID: 31128308
[TBL] [Abstract][Full Text] [Related]
15. Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.
Kellie SJ; Wong CK; Pozza LD; Waters KD; Lockwood L; Mauger DC; White L
Med Pediatr Oncol; 2002 Sep; 39(3):168-74. PubMed ID: 12210445
[TBL] [Abstract][Full Text] [Related]
16. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
Geyer JR; Sposto R; Jennings M; Boyett JM; Axtell RA; Breiger D; Broxson E; Donahue B; Finlay JL; Goldwein JW; Heier LA; Johnson D; Mazewski C; Miller DC; Packer R; Puccetti D; Radcliffe J; Tao ML; Shiminski-Maher T;
J Clin Oncol; 2005 Oct; 23(30):7621-31. PubMed ID: 16234523
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933.
MacDonald TJ; Arenson EB; Ater J; Sposto R; Bevan HE; Bruner J; Deutsch M; Kurczynski E; Luerssen T; McGuire-Cullen P; O'Brien R; Shah N; Steinbok P; Strain J; Thomson J; Holmes E; Vezina G; Yates A; Phillips P; Packer R
Cancer; 2005 Dec; 104(12):2862-71. PubMed ID: 16315242
[TBL] [Abstract][Full Text] [Related]
18. Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience.
Zaky W; Dhall G; Ji L; Haley K; Allen J; Atlas M; Bertolone S; Cornelius A; Gardner S; Patel R; Pradhan K; Shen V; Thompson S; Torkildson J; Sposto R; Finlay JL
Pediatr Blood Cancer; 2014 Jan; 61(1):95-101. PubMed ID: 23934933
[TBL] [Abstract][Full Text] [Related]
19. Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials.
Upadhyaya SA; Robinson GW; Onar-Thomas A; Orr BA; Johann P; Wu G; Billups CA; Tatevossian RG; Dhanda SK; Srinivasan A; Broniscer A; Qaddoumi I; Vinitsky A; Armstrong GT; Bendel AE; Hassall T; Partap S; Fisher PG; Crawford JR; Chintagumpala M; Bouffet E; Gururangan S; Mostafavi R; Sanders RP; Klimo P; Patay Z; Indelicato DJ; Nichols KE; Boop FA; Merchant TE; Kool M; Ellison DW; Gajjar A
Clin Cancer Res; 2021 May; 27(10):2879-2889. PubMed ID: 33737307
[TBL] [Abstract][Full Text] [Related]
20. Central nervous system atypical teratoid rhabdoid tumor: experience at the National Institute of Pediatrics, Mexico City.
de León-Bojorge B; Rueda-Franco F; Anaya-Jara M
Childs Nerv Syst; 2008 Mar; 24(3):307-12. PubMed ID: 17876589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
